Activity Details

Free CME
0.75 AMA PRA Category 1 Credit(s)
Released: July 31, 2020
Expires: July 31, 2021
45 minutes to complete

Accredited By

Target Audience

This educational initiative has been designed for family practice and primary care providers involved in the management of patients with obesity.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Employ proven communication and counseling strategies to effectively engage patients in weight loss discussion​
  • Examine regional and ethnic disparities to tailor obesity interventions appropriately​
  • Incorporate current practice guidelines and quality indicators to optimize obesity screening, diagnosis, and treatment​
  • Evaluate the efficacy and safety of available and emerging pharmacologic therapies for weight loss and weight maintenance

Activity Description

Obesity rates are increasing, and contrary to other major global risks, there is little evidence of successful population-level intervention strategies to reduce rates. As with all chronic medical conditions, effective management of obesity must be based on a partnership between a highly motivated patient and a committed team of clinicians. It is well known that there is a growing shortage of obesity specialists in the United States who diagnose and manage interrelated cardiometabolic diseases. Therefore, family practice physicians are expected to become the frontline providers to manage obesity in the near future.

A comprehensive, patient-centered approach to obesity improves patient outcomes, but rarely is implemented. In order for a patient-centered approach to be implemented, clinicians are required to know how to effectively engage their patients and be up-to-date on current medical anti-obesity therapies so they can select the most appropriate agent for their individual patient’s needs. This innovative activity will incorporate multiple evidence-based adult learning principles to improve family physicians' skills and confidence in weight-loss counseling and treatment.


Deborah Bade Horn, DO, MPH
Medical Director
Center for Obesity Medicine and Metabolic Performance
Clinical Assistant Professor
Department of Surgery
University of Texas McGovern Medical School
Houston, Texas

Conflict of Interest Policy/Disclosure Statement

Integrity Continuing Education, Inc. requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Integrity Continuing Education, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The following faculty/planners reported the financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of these CME activities:

Deborah Bade Horn, DO, MPH
Consulting Fees: Gelesis, Medtronic, Novo Nordisk
Speakers’ BureausNovo Nordisk
Contracted Research: Novo Nordisk 

Michelle R. Rizzo, ELS, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Accreditation Statement

Integrity Continuing Education, Inc. is accredited with commendation by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians.

Designation of Credit

Integrity Continuing Education, Inc. designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions for Receiving Credit

There are no fees for participating and receiving CME credit for this activity. During the period of July 31, 2020 through July 31, 2021, participants must:

  • Read the learning objectives and faculty disclosures
  • Complete the pretest
  • Study the educational activity
  • Complete the posttest and the evaluation form

A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed posttest with a score of 66% or better.

Disclaimer Statement/Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integrity Continuing Education, Inc. and Novo Nordisk, Inc. do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Contact Information for Questions About the Activity

For information about ACCME accreditation of this activity, please contact Integrity Continuing Education at (855) 835-4004 or

Statement of Commercial Support

Supported by an educational grant from Novo Nordisk, Inc.

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Start Activity

Select your specialty

You must select a specialty

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.